Replies to post #8512 on Marker Therapeutics Inc (MRKR)

[Rkmatters]

Huge market. Their market on HER2-neu vaccine alone is bigger than Herceptin, which a 6 billion a year in sales.

Read the 10q. :)

[Macgruber]

Breast & Ovarian trial and Her2/neu which have market potentials of ~1.4 Billion and ~10.5 Billion respectively per the 10q. Plenty big enough for a company valued at less than 20 mil. These are basement bargain prices. Buying cheaper than the the average weighed price of all the January and March warrants.